Records containing: Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-04-10Phase 1 Study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG, NSC #707545) in Patients With Solid Tumors.
-
CLINICAL_TRIALS study record update · 2013-04-02Multicenter Randomized Phase II Study of Erlotinib, Cisplatin and Radiotherapy Versus Cisplatin and Radiotherapy in Patients With Stage III and IV Squamous Cell Carcinoma of the Head and Neck
-
CLINICAL_TRIALS study record update · 2013-02-28A Phase I Trial of Herceptin and Interleukin-12
-
CLINICAL_TRIALS study record update · 2013-02-07A Phase I Study Of Bevacizumab (Recombinant Humanized Monoclonal Antibody To Vascular Endothelial Growth Factor) In Addition To Flourouracil And Hydroxyurea As Initial Chemotherapy With Concomitant Radiotherapy (B-FHX) For Poor Prognosis Head And Neck Cancer
-
CLINICAL_TRIALS study record update · 2013-01-25A Phase I Study Of ZD 1839 In Combination With Radiation And Chemotherapy In Locally Advanced Squamous Cell Carcinoma Of The Head And Neck
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-01-24A Phase I Study Of PV701 In Patients With Head And Neck Squamous Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2013-01-16Does Hypoxia Predict Radiation/Surgical Tumor Response/A Correlative Trial of EF5, an Agent for the Detection of Tumor Hypoxia
-
CLINICAL_TRIALS study record update · 2013-01-09A Pharmacogenetic and Pharmacodynamic Study of Erlotinib (OSI-774) Toxicity in Patients With Advanced Solid Tumors